[{"Assets_0_Q2_USD":411666000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-72132000.0,"NetIncomeLoss_1_Q2_USD":-50222000.0,"NetIncomeLoss_2_Q2_USD":-113234000.0,"StockholdersEquity_0_Q2_USD":305359000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20190805"}]